Zivo Bioscience, Inc. (ZIVO)

Kritische 8-K Meldungen

Datum	Meldung	Schwere	Filing	Auszug
23.12.2025	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	tion 13(a) of the Exchange Act. ☐ Item 5.02 – Departure of Directors or Certain Officers; Election of Directors;
18.08.2025	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	tion 13(a) of the Exchange Act. ☐ Item 5.02 – Departure of Directors or Certain Officers; Election of Directors;
17.07.2024	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	tion 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; A
06.06.2024	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	lan and will be subject to provisions thereof. Item 5.02 Departure of Directors or Certain Officers; Election of Direc

Stammdaten

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

Unternehmen & Branche

Name	Zivo Bioscience, Inc.
Ticker	ZIVO
CIK	0001101026
Boerse	US
Sektor	Healthcare
Industrie	Biotechnology
SIC	2836 · Biological Products, (No Diagnostic Substances)

Wertpapier & Kennzahlen

CUSIP	–
ISIN	–
Typ	Common Stock
Marktkapitalisierung	12,4 Mio. USD
Beta	0,51
Dividendenrendite	0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

Periode	Filing	Umsatz	Nettoergebnis	EPS	Aktiva	Eigenkapital
2025-09-30	10-Q	65,625	-1,033,056	-0.27	559,452	-3,286,603
2025-06-30	10-Q	53,400	-1,640,232	-0.43	703,327	-2,540,746
2025-03-31	10-Q	0	-4,211,188	-1.12	1,331,334	-1,617,277
2024-12-31	10-K	157,220	-13,384,836	-4.23	1,643,122	-514,897
2024-09-30	10-Q	31,500	-2,268,597	-0.67	495,587	-2,083,069
2024-06-30	10-Q	0	-8,236,368	-2.78	575,588	-2,295,614
2024-03-31	10-Q	35,720	-1,278,486	-0.47	816,396	-2,268,900
2023-12-31	10-K	27,650	-7,777,184	-4.60	555,715	-2,205,843
2023-09-30	10-Q	11,800	-1,824,922		2,102,037	-1,094,042
2023-06-30	10-Q	4,050	-2,070,572		710,330	-3,144,832
2023-03-31	10-Q	0	-1,973,142		1,127,964	-1,741,662
2022-12-31	10-K	0	-8,745,293		2,123,019	-10,622
2022-09-30	10-Q	0	-2,004,339		3,971,356	1,524,245
2022-06-30	10-Q	0	-2,071,839		5,864,608	3,010,423
2022-03-31	10-Q	0	-2,028,320		7,688,129	4,584,518
2021-12-31	10-K	0	-8,755,881		8,990,178	6,042,209
2021-09-30	10-Q	0	-1,551,624		10,971,590	7,770,629
2021-06-30	10-Q	0	-1,845,648		11,103,617	7,332,971
2021-03-31	10-Q	0	-2,218,978		648,884	-11,423,769
2020-12-31	10-K	20,000	-9,105,729		220,179	-11,310,614

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Datum	Insider	Rolle	Typ	Stückzahl	Kurs	Wert (USD)	Δ
2026-04-17	STROME MARK E	10% Owner	Open Market Purchase	100,000	2.00	200,000.00	+192,2%
2026-02-27	YALDOO LAITH L	Director, 10% Owner	Open Market Purchase	1,543	9.72	14,997.96	+14,4%
2026-02-12	STROME MARK E	10% Owner	Open Market Purchase	20,000	9.77	195,400.00	+187,8%
2026-02-10	YALDOO LAITH L	Director, 10% Owner	Open Market Purchase	2,434	10.27	24,997.18	+24,0%
2026-01-14	YALDOO LAITH L	Director, 10% Owner	Open Market Purchase	1,766	8.49	14,993.34	+14,4%
2025-11-28	YALDOO LAITH L	Director, 10% Owner	Open Market Purchase	2,777	9.00	24,993.00	+24,0%
2025-10-13	STROME MARK E	10% Owner	Open Market Purchase	20,259	12.34	249,996.06	+240,3%
2025-10-10	YALDOO LAITH L	Director, 10% Owner	Open Market Purchase	1,659	12.05	19,990.95	+19,2%
2025-09-30	YALDOO LAITH L	Director, 10% Owner	Open Market Purchase	15,322	15.99	244,998.78	+235,5%
2025-06-13	YALDOO LAITH L	Director, 10% Owner	Open Market Purchase	3,488	14.33	49,983.04	+48,0%

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.